Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Asset Growth Recovery in ProgressRecovering
Percentile Rank63
5Y CAGR-23.2%
Year-over-Year Change
Year-over-year total asset growth rate
5Y CAGR
-23.2%/yr
Long-term compound
Percentile
P63
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 46.17% |
| 2024 | 19.82% |
| 2023 | 226.38% |
| 2022 | -26.50% |
| 2021 | 24.75% |
| 2020 | 172.82% |
| 2019 | 332.16% |
| 2018 | -24.63% |
| 2017 | 0.00% |